What is the recommended dosing for Cefuroxime (Cefuroxime) in treating an uncomplicated Urinary Tract Infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime Dosing for Uncomplicated Urinary Tract Infections

For uncomplicated UTIs, cefuroxime should be dosed at 250 mg orally twice daily for 7-10 days, or as intravenous therapy at 750 mg every 8 hours when parenteral treatment is required.

Oral Cefuroxime (Cefuroxime Axetil) Dosing

Uncomplicated UTI:

  • Recommended dose: 250 mg twice daily 1, 2
  • Duration: 7-10 days (standard β-lactam duration for UTIs) 3
  • Alternative dosing option: Some studies have shown efficacy with a single daily dose of 250 mg taken at night with a milk drink for 10 days 4

Clinical Efficacy:

  • Clinical cure rates of 84.8-97% have been demonstrated in controlled trials 1, 2
  • Bacteriological clearance rates of 72-80.3% 1, 2
  • Comparable efficacy to other antibiotics like cefaclor, amoxicillin/clavulanate, and ofloxacin 1, 2

Parenteral Cefuroxime Dosing

Uncomplicated UTI:

  • Recommended dose: 750 mg every 8 hours 3
  • Duration: 5-10 days 3

Complicated UTI:

  • Recommended dose: 1.5 grams every 8 hours 3
  • Duration: Based on clinical response, typically 10-14 days

Dosage Adjustment for Renal Impairment

Creatinine Clearance (mL/min) Dose Frequency
>20 750 mg-1.5 grams q8h
10-20 750 mg q12h
<10 750 mg q24h*

*Patients on hemodialysis should receive an additional dose after dialysis 3

Antimicrobial Coverage

Cefuroxime demonstrates good activity against most common uropathogens:

  • Escherichia coli (the predominant pathogen in UTIs)
  • Klebsiella pneumoniae
  • Proteus mirabilis
  • Methicillin-sensitive Staphylococcus aureus 5

Important Considerations

  1. β-lactam limitations: β-lactams generally have inferior efficacy compared to other UTI antimicrobials and may have more adverse effects 6. Consider this when selecting therapy.

  2. Alternative agents: If local resistance patterns or patient factors preclude the use of cefuroxime, consider fluoroquinolones, nitrofurantoin, fosfomycin, or trimethoprim-sulfamethoxazole based on susceptibility 6.

  3. Monitoring: Continue therapy for at least 48-72 hours after the patient becomes asymptomatic 3.

  4. Common adverse effects: Primarily gastrointestinal disturbances including diarrhea (4%), nausea, and vomiting 5, 1.

  5. Administration: Oral cefuroxime axetil should be taken with food to enhance absorption 5.

While cefuroxime is an effective option for UTI treatment, it's worth noting that current guidelines often recommend other agents as first-line therapy for uncomplicated UTIs, with β-lactams generally considered alternative options when preferred agents cannot be used 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.